Multiple platforms of a HIV-2 derived lentiviral vector for expanded utility

Area of Science:

• Virology
• Molecular Biology
• Gene Therapy

Background:

• Lentiviral vectors (LVs) are crucial tools for gene transfer.
• Existing HIV-2 based LVs have limitations in versatility and application.
• Development of novel, adaptable LV systems is essential for advancing gene therapy research.

Purpose of the Study:

• To engineer a comprehensive panel of Human Immunodeficiency Virus type 2 (HIV-2) derived lentiviral transfer vectors.
• To introduce novel features such as blue/white screening, reduced backbone size, and dual tags.
• To create versatile vector systems with selectable markers and inducible expression for diverse gene transfer applications.

Main Methods:

• Derivation of multiple HIV-2 based lentiviral transfer vectors with varied configurations.
• Incorporation of selectable markers (neomycin, puromycin, hygromycin) and dual multiple cloning sites (MCS).
• Testing vector functionality through transgene expression assays in target cells post-transduction.

Main Results:

• Successful generation of novel transfer vectors with features like blue/white screening and dual tags.
• Development of vector panels offering selectable markers and drug-inducible transgene expression.
• Demonstrated efficient transgene expression across different vector formats via transduction.

Conclusions:

• The developed HIV-2 based lentiviral vector system is the most comprehensive to date.
• This versatile system significantly enhances utility for preferential gene transfer applications.
• The novel vector configurations provide advanced tools for gene therapy and molecular biology research.